Federal and Regulatory Outreach
AMRPA-Led Stakeholder Letter to CMS re: Time-Sensitive Review Choice Demonstration Concerns & Delay Request
August 11, 2023
Regulatory Review Choice Demonstration
AMRPA Submits Comments for IRF Review Choice Demonstration
June 23, 2023
Regulatory Review Choice Demonstration
AMRPA Submits Comments for Congressional Hearing on MA Denials and Delays
June 2, 2023
Legislative Medicare Advantage Prior Authorization
AMRPA Submits Comments on FY 2024 IRF PPS Proposed Rule
June 2, 2023
IRF PPS IRF QRP
AMRPA Letter to MedPAC re: Activity Not Attempted Codes in March 2023 Report to Congress
May 17, 2023
IRF QRP IRF-PAI MedPAC
AMRPA and ARN Comments on Senate HELP Committee Workforce RFI
March 22, 2023
Legislative
AMRPA Letter on Seat Elevation Systems National Coverage Determination
March 22, 2023
Regulatory
AMRPA’s Comments on Electronic Prior Authorization Rule
March 14, 2023
Prior Authorization Regulatory
AMRPA and NALTH Letter to CMS RE: QRP Reporting Requirements
March 8, 2023
IRF QRP Quality
AMRPA Comment Letter re: CY 2024 Policy and Technical Changes to MA Program Proposed Rule
February 14, 2023
Medicare Advantage Prior Authorization Regulatory
AMRPA 2022 First Round Comments re: NQF Measures Under Consideration for IRF QRP
December 13, 2022
IRF QRP
AMRPA Letter to CMS RE: IRF QRP Non-Compliance Determinations and Reconsideration Requests